You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Merck
Medtronic
Baxter
McKesson

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 6,984,772

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,984,772
Title:Transgenic non-human mammals producing fibrinogen in their milk
Abstract: A transgenic, non-human mammalian animal is capable of expressing a heterologous gene for human or other recombinant physiologically functional fibrinogen holoprotein or individual subunit chain polypeptides thereof or a modified or fusion fibrinogen in mammary glands of the animals and secreting the expressed product into a body fluid. Methodology employing such a mammal yields recombinant physiologically functional fibrinogens, subunit chain polypeptides thereof, and modified or fusion fibrinogens.
Inventor(s): Velander; William H. (Blacksburg, VA), Drohan; William N. (Springfield, VA), Lubon; Henryk (Rockville, MD), Johnson; John L. (Blacksburg, VA)
Assignee: Virginia Tech Intellectual Properties, Inc. (Blacksburg, VA) American Red Cross (Rockville, MD) The University of North Carolina at Chapel Hill (Chapel Hill, NC)
Application Number:08/443,184
Patent Claims:see list of patent claims

Details for Patent 6,984,772

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Virginia Tech Intellectual Properties, Inc. (Blacksburg, VA) American Red Cross (Rockville, MD) The University of North Carolina at Chapel Hill (Chapel Hill, NC) 2023-01-10 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Virginia Tech Intellectual Properties, Inc. (Blacksburg, VA) American Red Cross (Rockville, MD) The University of North Carolina at Chapel Hill (Chapel Hill, NC) 2023-01-10 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Virginia Tech Intellectual Properties, Inc. (Blacksburg, VA) American Red Cross (Rockville, MD) The University of North Carolina at Chapel Hill (Chapel Hill, NC) 2023-01-10 RX search
Csl Behring Gmbh RIASTAP fibrinogen human INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 125317 1 2009-01-16   Start Trial Virginia Tech Intellectual Properties, Inc. (Blacksburg, VA) American Red Cross (Rockville, MD) The University of North Carolina at Chapel Hill (Chapel Hill, NC) 2023-01-10 search
Octapharma Usa Inc FIBRYGA fibrinogen (human) KIT 125612 1 2017-10-16   Start Trial Virginia Tech Intellectual Properties, Inc. (Blacksburg, VA) American Red Cross (Rockville, MD) The University of North Carolina at Chapel Hill (Chapel Hill, NC) 2023-01-10 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Dow
Boehringer Ingelheim
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.